About Transave
Transave is a company based in Monmouth Junction (United States) founded in 1997 was acquired by Insmed in December 2010. Transave has raised $13.04 million across 3 funding rounds from investors including Insmed. Transave operates in a competitive market with competitors including MannKind Corp, aTyr Pharma, ReCode Therapeutics, Impel NeuroPharma and Sirnaomics, among others.
- Headquarter Monmouth Junction, United States
-
Sectors
TechnologyHealthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Transave Inc
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Transave
Transave has successfully raised a total of $13.04M across 3 strategic funding rounds. The most recent funding activity was a Series A round of $2 million completed in September 2010. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Transave
Transave has secured backing from 1 investor. Prominent investors backing the company include Insmed.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Developer of small molecule inhibitors for rare lung diseases
|
Locked | Locked | Locked |
Investor details for Transave
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Transave
Investment portfolio details for Transave
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Transave
Detailed financials for Transave
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Transave Comparisons
Peer comparison for Transave
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Transave
Transave operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as MannKind Corp, aTyr Pharma, ReCode Therapeutics, Impel NeuroPharma and Sirnaomics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Developer of small-molecule drugs
|
|
| Locked | Locked | Locked |
Protein biologics are developed for treating rare diseases.
|
|
| Locked | Locked | Locked |
Precision medicines for lung-related diseases are developed.
|
|
| Locked | Locked | Locked |
Intranasal delivery technology for CNS diseases is developed.
|
|
| Locked | Locked | Locked |
RNA-based therapeutics for cancer and fibrosis are developed.
|
|
| Locked | Locked | Locked |
Developer of products for the treatment of acute and intermittent conditions
|
Detailed competitors of Transave
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Transave
Complete news archive for Transave
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Transave
Transave was founded in 1997 and raised its 1st funding round 12 years after it was founded.
Transave is headquartered in Monmouth Junction, United States. It is registered at Monmouth Junction, New Jersey, United States.
Transave is a funded company, having raised a total of $13.04M across 3 funding rounds to date.
Transave was founded in 1997 in Monmouth Junction, United States, within the biotechnology sector. Inhaled pharmaceuticals are developed by the company for targeted treatment of serious lung infections. The lead product, ARIKACE (liposomal amikacin for inhalation), is being advanced for cystic fibrosis patients facing Pseudomonas infections and those due to non-tuberculous Mycobacteria. Operations focus on respiratory therapeutics, with development centered in the U.S.
Transave's top competitors include MannKind Corp, Sirnaomics and Arcturus Therapeutics.
Transave has 1 investor. Key investors include Insmed.